Chris Hibberd

Chris Hibberd has joined the board of directors of Oxford Genome Sciences. Hibberd is currently CEO of Astute Medical and is a former senior vice president of corporate development for Biosite. Prior to joining Biosite, he was a manager at the Boston Consulting Group.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.